Sign in
4

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-22-001715

Chief Financial Officer acquired 14,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Davis Blaine · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 1 in the form +14,100 15,581 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-03 Grant or award : show line 2 in the form Stock Option (Right to Buy) +84,800 84,800 D
Loading xslF345X03/doc4.xml…